ATRC
Price
$38.39
Change
-$0.77 (-1.97%)
Updated
Feb 21 closing price
Capitalization
1.45B
66 days until earnings call
XRAY
Price
$18.75
Change
-$0.20 (-1.06%)
Updated
Feb 21 closing price
Capitalization
6.69B
4 days until earnings call
Ad is loading...

ATRC vs XRAY

Header iconATRC vs XRAY Comparison
Open Charts ATRC vs XRAYBanner chart's image
AtriCure
Price$38.39
Change-$0.77 (-1.97%)
Volume$475.36K
Capitalization1.45B
DENTSPLY SIRONA
Price$18.75
Change-$0.20 (-1.06%)
Volume$1.77M
Capitalization6.69B
ATRC vs XRAY Comparison Chart
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRC vs. XRAY commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and XRAY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ATRC: $38.22 vs. XRAY: $18.84)
Brand notoriety: ATRC and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 150% vs. XRAY: 115%
Market capitalization -- ATRC: $1.45B vs. XRAY: $6.69B
ATRC [@Medical Specialties] is valued at $1.45B. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, XRAY is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 3 TA indicator(s) are bullish while XRAY’s TA Score has 3 bullish TA indicator(s).

  • ATRC’s TA Score: 3 bullish, 5 bearish.
  • XRAY’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ATRC is a better buy in the short-term than XRAY.

Price Growth

ATRC (@Medical Specialties) experienced а -7.93% price change this week, while XRAY (@Medical Specialties) price change was +3.06% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.56%. For the same industry, the average monthly price growth was -1.17%, and the average quarterly price growth was +2.64%.

Reported Earning Dates

ATRC is expected to report earnings on Apr 30, 2025.

XRAY is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Medical Specialties (-1.56% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XRAY($6.69B) has a higher market cap than ATRC($1.45B). ATRC has higher P/E ratio than XRAY: ATRC (36.76) vs XRAY (19.23). ATRC YTD gains are higher at: 25.065 vs. XRAY (-0.738). XRAY has higher annual earnings (EBITDA): 249M vs. ATRC (-8.11M). XRAY has more cash in the bank: 334M vs. ATRC (137M). ATRC has less debt than XRAY: ATRC (74.5M) vs XRAY (2.3B). XRAY has higher revenues than ATRC: XRAY (3.97B) vs ATRC (399M).
ATRCXRAYATRC / XRAY
Capitalization1.45B6.69B22%
EBITDA-8.11M249M-3%
Gain YTD25.065-0.738-3,398%
P/E Ratio36.7619.23191%
Revenue399M3.97B10%
Total Cash137M334M41%
Total Debt74.5M2.3B3%
FUNDAMENTALS RATINGS
ATRC vs XRAY: Fundamental Ratings
ATRC
XRAY
OUTLOOK RATING
1..100
1582
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
99100
SMR RATING
1..100
9294
PRICE GROWTH RATING
1..100
4362
P/E GROWTH RATING
1..100
9789
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (4) in the Medical Specialties industry is somewhat better than the same rating for ATRC (68). This means that XRAY’s stock grew somewhat faster than ATRC’s over the last 12 months.

ATRC's Profit vs Risk Rating (99) in the Medical Specialties industry is in the same range as XRAY (100). This means that ATRC’s stock grew similarly to XRAY’s over the last 12 months.

ATRC's SMR Rating (92) in the Medical Specialties industry is in the same range as XRAY (94). This means that ATRC’s stock grew similarly to XRAY’s over the last 12 months.

ATRC's Price Growth Rating (43) in the Medical Specialties industry is in the same range as XRAY (62). This means that ATRC’s stock grew similarly to XRAY’s over the last 12 months.

XRAY's P/E Growth Rating (89) in the Medical Specialties industry is in the same range as ATRC (97). This means that XRAY’s stock grew similarly to ATRC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCXRAY
RSI
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
72%
Bullish Trend 5 days ago
60%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
66%
MACD
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
66%
Advances
ODDS (%)
Bullish Trend 18 days ago
74%
Bullish Trend 24 days ago
58%
Declines
ODDS (%)
Bearish Trend 20 days ago
83%
Bearish Trend 12 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
58%
Aroon
ODDS (%)
Bullish Trend 5 days ago
70%
Bearish Trend 5 days ago
78%
View a ticker or compare two or three
Ad is loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with TFX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-6.64%
TFX - ATRC
44%
Loosely correlated
+1.13%
ABT - ATRC
41%
Loosely correlated
-0.33%
STE - ATRC
40%
Loosely correlated
+0.15%
NVST - ATRC
38%
Loosely correlated
+2.45%
XRAY - ATRC
38%
Loosely correlated
+2.84%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with HOLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then HOLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+2.84%
HOLX - XRAY
42%
Loosely correlated
+1.09%
TNDM - XRAY
40%
Loosely correlated
-2.54%
LH - XRAY
40%
Loosely correlated
-0.08%
MMSI - XRAY
40%
Loosely correlated
+1.15%
STE - XRAY
39%
Loosely correlated
+0.15%
More